BeiGene - Stock Price History | BGNE

Historical daily share price chart and data for BeiGene since 2021 adjusted for splits. The latest closing stock price for BeiGene as of October 27, 2021 is 367.27.
  • The all-time high BeiGene stock closing price was 403.14 on September 17, 2021.
  • The BeiGene 52-week high stock price is 426.56, which is 16.1% above the current share price.
  • The BeiGene 52-week low stock price is 219.20, which is 40.3% below the current share price.
  • The average BeiGene stock price for the last 52 weeks is 320.72.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
BeiGene Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 207.9582 165.9200 316.6100 121.8400 258.3900 55.88%
2019 140.3191 136.0300 208.3400 113.9900 165.7600 18.18%
2018 153.8827 100.8100 216.7700 97.4100 140.2600 43.53%
2017 60.5702 31.0500 114.7300 30.8100 97.7200 221.87%
2016 29.6449 28.3200 36.9000 23.9800 30.3600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $35.804B $0.309B
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86